Your search returned 6 results.

Results
	1.	Improvement in health-related quality of life with recombinant factor IX prophylaxis in severe or moderately severe haemophilia B patients: results from the BAX326 Pivotal Study. [electronic resource] by Windyga, J Lin, V W Epstein, J D Ito, D Xiong, Y Abbuehl, B E Ramirez, J H Producer: 20150220 In: Haemophilia : the official journal of the World Federation of Hemophilia vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Extended half-life pegylated, full-length recombinant factor VIII for prophylaxis in children with severe haemophilia A. [electronic resource] by Mullins, E S Stasyshyn, O Alvarez-Román, M T Osman, D Liesner, R Engl, W Sharkhawy, M Abbuehl, B E Producer: 20170327 In: Haemophilia : the official journal of the World Federation of Hemophilia vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Efficacy and safety of a recombinant factor IX (Bax326) in previously treated patients with severe or moderately severe haemophilia B undergoing surgical or other invasive procedures: a prospective, open-label, uncontrolled, multicentre, phase III study. [electronic resource] by Windyga, J Lissitchkov, T Stasyshyn, O Mamonov, V Ghandehari, H Chapman, M Fritsch, S Wong, W-Y Pavlova, B G Abbuehl, B E Producer: 20150518 In: Haemophilia : the official journal of the World Federation of Hemophilia vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Efficacy and safety of pegylated full-length recombinant factor VIII with extended half-life for perioperative haemostasis in haemophilia A patients. [electronic resource] by Brand, B Gruppo, R Wynn, T T Griskevicius, L Lopez Fernandez, M F Chapman, M Dvorak, T Pavlova, B G Abbuehl, B E Producer: 20170216 In: Haemophilia : the official journal of the World Federation of Hemophilia vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Recombinant factor IX (BAX326) in previously treated paediatric patients with haemophilia B: a prospective clinical trial. [electronic resource] by Urasinski, T Stasyshyn, O Andreeva, T Rusen, L Perina, F G Oh, M S Chapman, M Pavlova, B G Valenta-Singer, B Abbuehl, B E Producer: 20151021 In: Haemophilia : the official journal of the World Federation of Hemophilia vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Pharmacokinetics, efficacy and safety of BAX326, a novel recombinant factor IX: a prospective, controlled, multicentre phase I/III study in previously treated patients with severe (FIX level <1%) or moderately severe (FIX level ≤2%) haemophilia B. [electronic resource] by Windyga, J Lissitchkov, T Stasyshyn, O Mamonov, V Rusen, L Lamas, J L Oh, M-S Chapman, M Fritsch, S Pavlova, B G Wong, W-Y Abbuehl, B E Producer: 20140808 In: Haemophilia : the official journal of the World Federation of Hemophilia vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)